However, Mtb has been shown to have the ability to deactivate NOX2-derived ROS (Miller et al., 2010), although it is still unclear if there is increased susceptibility to TB in patients with chronic granulomatous disease (CGD) that causes ROS defects as a result of genetic defects in NADPH oxidase. Here, FMO5 is linked to chronic granulomatous disease.